Background Antituberculosis treatment (ATT) induced hepato-toxicity is common, but risk
factors predicting its development are poorly understood. The present study evaluates the …

Background & objectives: Antituberculosis (anti-TB) drug induced hepatotoxicity (DIH) is the
most common side effect leading to interruption of therapy. Wide variations have been found …

Background: Tuberculosis (TB) is a very common droplet infection especially in the northern
areas. If untreated, the disease may be fatal within 5 years in more than half of cases. To …

ABSTRACT OBJECTIVE: To determine the frequency of hepatotoxicity with standard
antituberculosis drug therapy and its risk factors. METHOD: This prospective cohort study …

Background: Tuberculosis is a global pandemic which affects millions of people every year.
The treatment of tuberculosis consists of simultaneous use of a number of drugs for a …

Objective: To assess the severity and frequency of hepatotoxicity caused by different
antituberculosis (ATT) drugs and to evaluate whether concurrence of risk factors influence …

Background & objectives: Drug induced hepatotoxicity (DIH) is an important and commonly
encountered adverse effect with antituberculosis (anti-TB) treatment. Acute viral hepatitis …

Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious
adverse effect of tuberculosis (TB) treatment. This retrospective study was carried out to …

Purpose Identification of risk factors associated with antituberculosis drug-induced
hepatotoxicity (anti-TB-DIH) is important, especially in endemic area for TB and liver …

The drug-induced hepatotoxicity is a significantly increasing problem worldwide, but it is of
more concern in the treatment of tuberculosis (TB) infection, especially in a third world …